Projects per year
Projects
- 17 Finished
Search results
-
Finished
Strategic expansion of preclinical ultrasound imaging facility
Moran, C. (Principal Investigator), Baker, A. (Co-investigator), Chapman, K. (Co-investigator), Eddleston, M. (Co-investigator), Evans, M. (Co-investigator), Gray, G. (Co-investigator) & Holmes, M. (Co-investigator)
1/01/19 → 31/12/22
Project: Research
-
Does glucocorticoid action regulate cardiomyocyte proliferation and binucleation?
Ivy, J. (Principal Investigator) & Chapman, K. (Co-investigator)
28/05/18 → 3/08/18
Project: Research
-
GLUCOCORTICOID RECEPTOR IN THE EARLY LIFE PROGRAMMING OF CARDIAC RESILIANCE
Chapman, K. (Principal Investigator), Denvir, M. (Co-investigator), Gray, G. (Co-investigator) & Holmes, M. (Co-investigator)
1/12/16 → 30/11/19
Project: Research
-
Can mineralcorticoid receptor antangonism prevent cardiac fibrosis caused by gluococorticoid receptor deficiency?
Chapman, K. (Principal Investigator)
1/01/15 → 30/03/15
Project: Research
-
SUMMER STUDENTSHIP - WIKTORIA WYRZYKOWSKA
Chapman, K. (Principal Investigator)
28/05/12 → 3/08/12
Project: Research
-
11b-HSD1 a new biomarker of drug sesnsitivity in childhood acute lymphoblasticleukaemia
Chapman, K. (Principal Investigator)
UK central government bodies/local authorities, health and hospital authorities
1/04/11 → 31/03/12
Project: Research
-
11B-HSD1 as a therapeutic target in repair following myocardial infarction
Gray, G. (Principal Investigator), Chapman, K. (Co-investigator), Hadoke, P. (Co-investigator) & Walker, B. (Co-investigator)
1/01/11 → 31/05/14
Project: Research
-
How does 11B-hydroxysteriod dehydrogenase type 1 limit inflammation.
Chapman, K. (Principal Investigator), Gray, M. (Co-investigator), Savill, J. (Co-investigator) & Seckl, J. (Co-investigator)
1/10/08 → 30/04/12
Project: Research
-
11Beta hydroxystereoid dehydrogenase type 1 and atheroscerosis risk.
Chapman, K. (Principal Investigator), Mullins, J. (Co-investigator), Savill, J. (Co-investigator), Seckl, J. (Co-investigator) & Walker, B. (Co-investigator)
1/01/08 → 31/05/13
Project: Research
-
Functional importance of RNA editing of the 5-HT2C receptor in vivo using a gene-targeting approach
Holmes, M. (Principal Investigator) & Chapman, K. (Co-investigator)
14/04/07 → 13/03/11
Project: Research
-
ADIPOCYTE GLUCOCORTICOID RECEPTORS IN THE DEVELOPMENT OF HYPERTENSION AND THE METABOLIC SYNDROME
Chapman, K. (Principal Investigator)
1/02/05 → 31/05/13
Project: Research
-
The cellular and molecular basis of disease: Studentship for mis zoi Michailidou
Chapman, K. (Principal Investigator)
1/10/03 → 30/09/07
Project: Research
-
THE MOLECULAR BASIS FOR GLUCOCORTICOID EFFICACY IN LEUKAEMIA TREATMENT
Chapman, K. (Principal Investigator), Blackburn, C. (Co-investigator) & Holmes, M. (Co-investigator)
1/04/03 → 31/07/06
Project: Research
-
S/Ship R A De Sosa Peixoto
Chapman, K. (Principal Investigator), Morton, N. (Co-investigator) & Seckl, J. (Co-investigator)
1/01/03 → 31/12/05
Project: Research
-
Conditional overexpression of 5-HRT 2c receptors in mice
Chapman, K. (Principal Investigator) & Holmes, M. (Co-investigator)
1/06/02 → 28/02/06
Project: Research
-
Characterisation of a novel prostrate derived growth factor which controls prostrate epithelial cells phenotype
Habib, F. (Principal Investigator) & Chapman, K. (Co-investigator)
1/04/02 → 30/09/03
Project: Research
-
11B-hydroxysteroid dehydrogenase type1: a key amplifier of glucocorticoid action
Chapman, K. (Principal Investigator), Mullins, J. (Co-investigator), Seckl, J. (Co-investigator) & Walker, B. (Co-investigator)
1/03/02 → 30/11/07
Project: Research